Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma

Expression analysis of CD44 isoforms S and V3, in patients with esophageal squamous cell carcinoma

Bibliographic Details
Main Authors:	Mansouri, Atena, Foroughmand, Ali Mohammad, Abbaszadegan, Mohammad Reza, Memar, Bahram, Mahmoudian, Reihaneh Alsadat, Gholamin, Mehran
Format:	Online
Language:	English
Published:	Mashhad University of Medical Sciences 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4439453/

Similar Items

Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients
by: Forghanifard, Mohammad Mahdi, et al.
Published: (2016)

Contribution of KCTD12 to esophageal squamous cell carcinoma
by: Mohammad Reza Abbaszadegan, et al.
Published: (2018-08-01)

WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma
by: Mohammad Reza Abbaszadegan, et al.
Published: (2018-09-01)

Role of Brg1 in progression of esophageal squamous cell carcinoma
by: Torkamandi, Shahram, et al.
Published: (2014)

Expression and modulation of CD44 variant isoforms in humans
Published: (1994)

CD44v3 and v6 variant isoform expression correlates with poor prognosis in early-stage vulvar cancer.
by: Tempfer, C., et al.
Published: (1998)

CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells
by: Erb, Ulrike, et al.
Published: (2014)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
by: Biddle, Adrian, et al.
Published: (2013)

Mastermind-like 1 (MAML-1) as a new metastatic marker in esophageal squamous cell carcinoma
by: Forghanifard, Mohammad M, et al.
Published: (2010)

Association of ADAM33 gene polymorphisms with allergic asthma
by: Karimi, Mohammad Reza Zand, et al.
Published: (2014)

Role of Oxidative Stress in Modulating Unfolded Protein Response Activity in Chronic Myeloid Leukemia Cell Line
by: Bazi, Ali, et al.
Published: (2016)

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
Published: (1995)

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
by: Zeimet, A. G., et al.
Published: (1997)

Tax promotes the expression of the alternative spliced isoform CD44v10 by slowing down the elongating RNA polymerase II
by: Thenoz, Morgan, et al.
Published: (2014)

SC35 promotes splicing of the C5-V6-C6 isoform of CD44 pre-mRNA
by: LOH, TIING JEN, et al.
Published: (2014)

Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44
by: Zhao, Jiang-Sha, et al.
Published: (2011)

Investigation of melanoma-associated antigen A4 cancer/testis antigen clinical relevance in esophageal squamous cell carcinoma
by: Soodabeh Abbasi Sani, et al.
Published: (2018-01-01)

The tumor suppressive role of NUMB isoform 1 in esophageal squamous cell carcinoma
by: Hong, Junmou, et al.
Published: (2014)

Linc-ROR and its spliced variants 2 and 4 are significantly up-regulated in esophageal squamous cell carcinoma
by: Sahebi, Reza, et al.
Published: (2016)

The prognostic value of CD44 isoform expression in endometrial cancer.
by: Tempfer, C., et al.
Published: (1998)

Distinct effects of two CD44 isoforms on tumor growth in vivo
Published: (1991)

The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study
by: Kazem Anvari, et al.
Published: (2017-02-01)

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
by: Hu, Bangli, et al.
Published: (2015)

Cell Membrane CD44v6 Levels in Squamous Cell Carcinoma of the Lung: Association with High Cellular Proliferation and High Concentrations of EGFR and CD44v5
by: Ruibal, Álvaro, et al.
Published: (2015)

Immunohistochemical analysis of CD44s and CD44v6 in endometriosis and adenomyosis : comparison with normal, hyperplastic, and malignant endometrium.
by: Lin, Z., et al.
Published: (2001)

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression
by: Zhe Wang, et al.
Published: (2018-08-01)

CD44v/CD44s expression patterns are associated with the survival of pancreatic carcinoma patients
by: Li, Zhonghu, et al.
Published: (2014)

Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells
Published: (1991)

Dual role of CD44 isoforms in ampullary adenocarcinoma: CD44s predicts poor prognosis in early cancer and CD44ν is an indicator for recurrence in advanced cancer
by: Wu, Cheng-Lin, et al.
Published: (2015)

PDGF Suppresses the Sulfation of CD44v and Potentiates CD44v-Mediated Binding of Colon Carcinoma Cells to Fibrin under Flow
by: Alves, Christina S., et al.
Published: (2012)

Detection of Malignant Cells in Pleural Fluid or Ascites by CD44v8-10/CD44v10 competitive RT-PCR
by: Ahn, Myung-Ju, et al.
Published: (2001)

Characterization of CD44 variant expression in head and neck squamous cell carcinomas
by: Spiegelberg, D., et al.
Published: (2013)

Expression of COX-2, CD44v6 and CD147 and Relationship with Invasion and Lymph Node Metastasis in Hypopharyngeal Squamous Cell Carcinoma
by: Yang, Qing, et al.
Published: (2013)

CD44v3+/CD24− cells possess cancer stem cell-like properties in human oral squamous cell carcinoma
by: TODOROKI, KEITA, et al.
Published: (2015)

Quantitative Immunohistochemical Analyses of the Expression of E-Cadherin, Thrombomodulin, CD44H and CD44v6 in Primary Tumours of pharynx/larynx Squamous Cell Carcinoma and their Lymph Node Metastases
by: Gaspar, Rocío Hernández, et al.
Published: (1999)

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin
Published: (1993)

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma
by: Gun, Banu Dogan, et al.
Published: (2012)

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
by: Shi, Jun, et al.
Published: (2013)

Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6
by: JI, FAHE, et al.
Published: (2014)

Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis
by: Zhang, Yunyuan, et al.
Published: (2016)